Current Vascular Pharmacology
Title:Editorial (Thematic Issue: Vascular Dysfunction in Obesity and Insulin Resistance)
Volume: 12 Issue: 3
Author(s): Dolores Prieto
Affiliation:
Export Options
About this article
Cite this article as:
Prieto Dolores, Editorial (Thematic Issue: Vascular Dysfunction in Obesity and Insulin Resistance), Current Vascular Pharmacology 2014; 12 (3) . https://dx.doi.org/10.2174/157016111203140518154828
DOI https://dx.doi.org/10.2174/157016111203140518154828 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery A Summary of Electrospun Nanofibers as Drug Delivery System: Drugs Loaded and Biopolymers Used as Matrices
Current Drug Delivery Treatment with Cinacalcet in Hemodialysis Patients with Severe Secondary Hyperparathyroidism, Influences Bone Mineral Metabolism and Anemia Parameters
Current Drug Therapy Physio-Pathological Consequences of Marginal or Severe Thiamin Deficiencies in Western Countries and the Potential of Cereal Products in Their Prevention
Current Nutrition & Food Science PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Postconditioning: A New Paradigm for Myocardial Protection?
Current Cardiology Reviews Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders
Current Neuropharmacology Tetrahydrobiopterin Biosynthesis, Utilization and Pharmacological Effects
Current Drug Metabolism Stem Cell Therapy for the Treatment of Myocardial Infarction
Current Pharmaceutical Design Trends in Utilization of the Pharmacological Potential of Chalcones
Current Clinical Pharmacology Perinatal Management of Fetal Tumors
Current Pediatric Reviews Acute Actions of Natriuretic Peptides in Coronary Vasculature and Ischaemic Myocardium
Current Pharmaceutical Design Cardiovascular Drug Development Using Radiopharmaceuticals
Current Pharmaceutical Design Going Beyond Anthracyclines and Taxanes in Breast Cancer – What’s Next?
Current Cancer Therapy Reviews Prevention of Endothelial Dysfunction and Cardiovascular Disease by n-3 Fatty Acids-Inhibiting Action on Oxidative Stress and Inflammation
Current Pharmaceutical Design All in the Family: The TNF-TNFR Superfamily in the Pathogenesis and Treatment of Rheumatoid Arthritis and other Inflammatory Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Metabolomic and Imaging: A Literature Review
Current Medical Imaging Newer Approaches to the Discovery of Glitazones
Mini-Reviews in Organic Chemistry Vasostatins and Negative Inotropy in Vertebrate Hearts
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets